Axsome Therapeutics (AXSM) Net Margin (2022 - 2025)
Historic Net Margin for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to 27.62%.
- Axsome Therapeutics' Net Margin rose 340400.0% to 27.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 40.89%, marking a year-over-year increase of 509800.0%. This contributed to the annual value of 74.47% for FY2024, which is 139400.0% up from last year.
- Per Axsome Therapeutics' latest filing, its Net Margin stood at 27.62% for Q3 2025, which was up 340400.0% from 31.95% recorded in Q2 2025.
- Axsome Therapeutics' 5-year Net Margin high stood at 11.88% for Q1 2023, and its period low was 469.82% during Q2 2022.
- Over the past 4 years, Axsome Therapeutics' median Net Margin value was 91.09% (recorded in 2024), while the average stood at 128.84%.
- Per our database at Business Quant, Axsome Therapeutics' Net Margin surged by 3259900bps in 2023 and then tumbled by -792600bps in 2024.
- Quarter analysis of 4 years shows Axsome Therapeutics' Net Margin stood at 251.29% in 2022, then soared by 45bps to 137.89% in 2023, then surged by 54bps to 63.08% in 2024, then surged by 56bps to 27.62% in 2025.
- Its last three reported values are 27.62% in Q3 2025, 31.95% for Q2 2025, and 48.91% during Q1 2025.